335 related articles for article (PubMed ID: 9422525)
1. The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.
Dillon DA; D'Aquila T; Reynolds AB; Fearon ER; Rimm DL
Am J Pathol; 1998 Jan; 152(1):75-82. PubMed ID: 9422525
[TBL] [Abstract][Full Text] [Related]
2. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer.
Nakopoulou L; Zervas A; Gakiopoulou-Givalou H; Constantinides C; Doumanis G; Davaris P; Dimopoulos C
Anticancer Res; 2000; 20(6B):4571-8. PubMed ID: 11205306
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps.
Valizadeh A; Karayiannakis AJ; el-Hariry I; Kmiot W; Pignatelli M
Am J Pathol; 1997 Jun; 150(6):1977-84. PubMed ID: 9176391
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Winn-Deen E; Oliver J; Fisher HA; Kaufman RP; Ross JS
Cancer; 2001 Dec; 92(11):2786-95. PubMed ID: 11753952
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
[TBL] [Abstract][Full Text] [Related]
8. Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.
Nakopoulou L; Gakiopoulou-Givalou H; Karayiannakis AJ; Giannopoulou I; Keramopoulos A; Davaris P; Pignatelli M
Histopathology; 2002 Jun; 40(6):536-46. PubMed ID: 12047765
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines.
Husmark J; Heldin NE; Nilsson M
Int J Cancer; 1999 Nov; 83(5):692-9. PubMed ID: 10521809
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
Moreno-Bueno G; Hardisson D; Sarrió D; Sánchez C; Cassia R; Prat J; Herman JG; Esteller M; Matías-Guiu X; Palacios J
J Pathol; 2003 Apr; 199(4):471-8. PubMed ID: 12635138
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of E-cadherin associated with alpha- and beta-catenins and p120ctn to the nectin-based cell-cell adhesion sites by the action of 12-O-tetradecanoylphorbol-13-acetate in MDCK cells.
Okamoto R; Irie K; Yamada A; Katata T; Fukuhara A; Takai Y
Genes Cells; 2005 May; 10(5):435-45. PubMed ID: 15836772
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
13. Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer.
Miyamoto S; Baba H; Kuroda S; Kaibuchi K; Fukuda T; Maehara Y; Saito T
Br J Cancer; 2000 Nov; 83(9):1168-75. PubMed ID: 11027430
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between p120ctn translocation and malignant features of hepatocellular carcinoma].
Huang HY; Nong CZ; He WS; Guo LX; Nong SY; Pan LL; Zha XL
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):398-402. PubMed ID: 15355642
[TBL] [Abstract][Full Text] [Related]
15. E- and N-cadherin differ with respect to their associated p120ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells.
Seidel B; Braeg S; Adler G; Wedlich D; Menke A
Oncogene; 2004 Jul; 23(32):5532-42. PubMed ID: 15107817
[TBL] [Abstract][Full Text] [Related]
16. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease.
Karayiannakis AJ; Syrigos KN; Efstathiou J; Valizadeh A; Noda M; Playford RJ; Kmiot W; Pignatelli M
J Pathol; 1998 Aug; 185(4):413-8. PubMed ID: 9828841
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.
Stefansson IM; Salvesen HB; Akslen LA
J Clin Oncol; 2004 Apr; 22(7):1242-52. PubMed ID: 15051772
[TBL] [Abstract][Full Text] [Related]
19. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
20. Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes.
Shibamoto S; Hayakawa M; Takeuchi K; Hori T; Miyazawa K; Kitamura N; Johnson KR; Wheelock MJ; Matsuyoshi N; Takeichi M
J Cell Biol; 1995 Mar; 128(5):949-57. PubMed ID: 7876318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
